Search

everythinglearnresearchcommunity

for

Search:↓

The TRPV3 channel structure changes linked to severe itch and hyperkeratosis were identified using cryo-EM.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

TAK-279 effectively reduces psoriasis symptoms and is safe.

TRPV1 affects sebaceous gland function and could help treat acne.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Adding a second method to PROTACs could improve cancer treatment.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

The study aims to find the best PRP dose for treating moderate carpal tunnel syndrome.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Regional nerve blocks are better than ring blocks for pain relief during PRP hair treatment.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.